<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Aprepitant</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Aprepitant">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Aprepitant</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Aprepitant</b>, sold under the brand name <b>Emend</b> among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.<span class="mw-ref" id="cite_ref-AHFS2019_1-0"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may be used together with <a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">ondansetron</a> and <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>.<span class="mw-ref" id="cite_ref-AHFS2019_1-1"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_1-2"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>



<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Aprepitant</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Aprepitant.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Aprepitant.svg.png" data-file-width="512" data-file-height="266" data-file-type="drawing" height="104" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Aprepitant_3D_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Aprepitant_3D_ball.png" data-file-width="2000" data-file-height="1017" data-file-type="bitmap" height="102" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Emend</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html'" tppabs="https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a604003.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a604003.html'" tppabs="https://medlineplus.gov/druginfo/meds/a604003.html" class="external text external">a604003</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Aprepitant  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Aprepitant'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Aprepitant" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aprepitant  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aprepitant'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aprepitant" class="external text external">Aprepitant</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (capsules)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>A04AD12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A04AD12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A04AD12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A04AD12" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>60–65%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;95%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (mostly CYP3A4- mediated; some contributions by CYP2C19 &amp; CYP1A2)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>9–13 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (5%), faeces (86%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">5-([(2<i>R</i>,3<i>S</i>)-2-((<i>R</i>)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy)-3-(4-fluorophenyl)morpholino]methyl)-1<i>H</i>-1,2,4-triazol-3(2<i>H</i>)-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=170729-80-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=170729-80-3'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=170729-80-3" class="external text external">170729-80-3</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/6918365  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/6918365'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/6918365" class="external text external">6918365</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3490  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3490'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3490" class="external text external">3490</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00673  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00673'" tppabs="https://www.drugbank.ca/drugs/DB00673" class="external text external">DB00673</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5293568.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5293568.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5293568.html" class="external text external">5293568</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1NF15YR6UY  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1NF15YR6UY'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1NF15YR6UY" class="external text external">1NF15YR6UY</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:499361  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:499361'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:499361" class="external text external">CHEBI:499361</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1471'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1471" class="external text external">ChEMBL1471</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3049047  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3049047'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3049047" class="external text external">DTXSID3049047</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.202.762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.202.762'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.202.762" class="external text external">100.202.762</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>23</sub><span>H</span><sub>21</sub><span>F</span><sub>7</sub><span>N</span><sub>4</sub><span>O</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">534.435</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28cc%28c1%29C%28F%29%28F%29F%29%5BC%40H%5D%28O%5BC%40H%5D4OCCN%28CC%2F2%3DN%2FC%28%3DO%29NN%5C2%29%5BC%40H%5D4c3ccc%28F%29cc3%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28cc%28c1%29C%28F%29%28F%29F%29%5BC%40H%5D%28O%5BC%40H%5D4OCCN%28CC%2F2%3DN%2FC%28%3DO%29NN%5C2%29%5BC%40H%5D4c3ccc%28F%29cc3%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=FC%28F%29%28F%29c1cc%28cc%28c1%29C%28F%29%28F%29F%29%5BC%40H%5D%28O%5BC%40H%5D4OCCN%28CC%2F2%3DN%2FC%28%3DO%29NN%5C2%29%5BC%40H%5D4c3ccc%28F%29cc3%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@H](O[C@H]4OCCN(CC/2=N/C(=O)NN\2)[C@H]4c3ccc(F)cc3)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:ATALOFNDEOCMKK-OITMNORJSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457136600&page2=Aprepitant  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457136600&page2=Aprepitant'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457136600&page2=Aprepitant" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.<span class="mw-ref" id="cite_ref-AHFS2019_1-3"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Other severe side effects may include anaphylaxis.<span class="mw-ref" id="cite_ref-AHFS2019_1-4"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> While use in pregnancy does not appear to be harmful, such use has not been well studied.<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Aprepitant belongs to the class of neurokinin-1 receptor antagonists medications.<span class="mw-ref" id="cite_ref-AHFS2019_1-5"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It works by blocking substance P from attaching to the NK1 receptors.<span class="mw-ref" id="cite_ref-EU2019_3-0"><a href="#cite_note-EU2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<p>Aprepitant was approved for medical use in Europe and the United States in 2003.<span class="mw-ref" id="cite_ref-AHFS2019_1-6"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-EU2019_3-1"><a href="#cite_note-EU2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is made by Merck &amp; Co.<span class="mw-ref" id="cite_ref-AHFS2019_1-7"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_4-0"><a href="#cite_note-WHO21st-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> A form that can be given by injection into a vein, known as fosaprepitant is also available.<span class="mw-ref" id="cite_ref-AHFS2019_1-8"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    

<p>Aprepitant is used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.<span class="mw-ref" id="cite_ref-AHFS2019_1-9"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Safety and usefulness of long term use or in those who already have nausea is unclear.<span class="mw-ref" id="cite_ref-AHFS2019_1-10"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>It may be used together with <a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">ondansetron</a> and <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>.<span class="mw-ref" id="cite_ref-AHFS2019_1-11"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_1-12"><a href="#cite_note-AHFS2019-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    

<p>Aprepitant is classified as an NK<sub>1</sub> antagonist because it blocks signals given off by NK<sub>1</sub> receptors. This, therefore, decreases the likelihood of vomiting in patients.</p>

<p>NK<sub>1</sub> is a G protein-coupled receptor located in the central and peripheral nervous system. This receptor has a dominant ligand known as Substance P (SP). SP is a neuropeptide, composed of 11 amino acids, which sends impulses and messages from the brain. It is found in high concentrations in the vomiting center of the brain, and, when activated, it results in a vomiting reflex. In addition to this it also plays a key part in the transmission of pain impulses from the peripheral receptors to the central nervous system.</p>

<p>Aprepitant has been shown to inhibit both the acute and delayed emesis induced by cytotoxic chemotherapeutic drugs by blocking substance P landing on receptors in the brain's neurons. Positron emission tomography (PET) studies, have demonstrated that aprepitant can cross the blood brain barrier and bind to NK<sub>1</sub> receptors in the human brain.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  It has also been shown to increase the activity of the 5-HT3 receptor antagonists <a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">ondansetron</a> and the corticosteroid <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>, which are also used to prevent nausea and vomiting caused by chemotherapy.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Aprepitant is taken orally in the form of a capsule. Before clinical testing, a new class of therapeutic agent has to be characterized in terms of preclinical metabolism and excretion studies.  Average bioavailability is found to be around 60-65%.  Aprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19. Seven metabolites of aprepitant, which are only weakly active, have been identified in human plasma.  As a moderate inhibitor of CYP3A4, aprepitant can increase plasma concentrations of co-administered medicinal products that are metabolized through CYP3A4. Specific interaction has been demonstrated with <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, where aprepitant both increased the efficacy and worsened the side effects of oxycodone; however it is unclear whether this is due to CPY3A4 inhibition or through its NK-1 antagonist action.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Following IV administration of a <sup>14</sup>C-labeled prodrug of aprepitant (L-758298), which is converted rapidly and completely to aprepitant, approximately 57% of the total radioactivity is excreted in the urine and 45% in feces. No unchanged substance is excreted in urine.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Structure_and_properties">Structure and properties</h2></summary>
    

<p>Aprepitant is made up of a <a href="Morpholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morpholine" title="Morpholine">morpholine</a> core with two substituents attached to adjacent ring carbons. These substitute groups are trifluoromethylated 1-phenylethanol and <a href="javascript:if(confirm('https://en.wiktionary.org/wiki/fluorophenyl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wiktionary.org/wiki/fluorophenyl'" tppabs="https://en.wiktionary.org/wiki/fluorophenyl" title="wikt:fluorophenyl" class="external">fluorophenyl</a> group. Aprepitant also has a third substituent (<span class="new">triazolinone</span>), which is joined to the morpholine ring <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a>. It has three chiral centres very close together, which combine to produce an amino acetal arrangement. Its empirical formula is C<sub>23</sub>H<sub>21</sub>F<sub>7</sub>N<sub>4</sub>O<sub>3</sub>.</p>

<p>Aprepitant is an off-white crystalline solid that has a molecular weight of around 534.53.  It has a very limited solubility in water. It does have a reasonably high solubility in non-polar molecules such as oils. This would, therefore, suggest that aprepitant as a whole, despite having components that are polar, is a non-polar substance.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Synthesis">Synthesis</h2></summary>
    

<p>Shortly after Merck initiated research into reducing the severity and likelihood of CINV, researchers discovered that aprepitant is effective in prevention. Researchers worked on coming up with a process to create aprepitant, and within a short period they came up with effective synthesis of the substance. This original synthesis was deemed to be workable and proved to be a crucial step in achieving commercialization; however, Merck decided that the process was not environmentally sustainable.  This was due to the original synthesis requiring six steps, many of which needed dangerous chemicals such as <a href="Sodium_cyanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_cyanide" title="Sodium cyanide">sodium cyanide</a>, dimethyltitanocene, and gaseous ammonia. In addition to this, for the process to be effective cryogenic temperatures were needed for some of the steps and other steps produced hazardous byproducts such as methane.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>  The environmental concerns of the synthesis of aprepitant became so great that Merck research team decided to withdraw the drug from clinical trials and attempt to create a different synthesis of aprepitant.<span class="mw-ref" id="cite_ref-NYAoS2011_10-0"><a href="#cite_note-NYAoS2011-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>The gamble of taking the drug out of clinical trials proved to be successful when shortly afterwards the team of Merck researchers came up with an alternative and more environmentally friendly synthesis of aprepitant. The new process works by four compounds of similar size and complexity being fused together. This therefore is a much simpler process and requires only three steps, half the number of the original synthesis.</p>

<p>The new process begins by enantiopure trifluoromethylated phenyl ethanol being joined to a racemic morpholine precursor. This results in the wanted isomer crystallizing on the top of the solution and the unwanted isomer remaining in the solution. The unwanted isomer is then converted to the wanted one by the chemist controlling the reaction conditions and a process known as crystallization-induced asymmetric transformation occurring. By the end of this step a secondary amine, the base of the drug, is formed.</p>

<p>The second step involves the fluorophenyl group being attached to the morpholine ring. Once this has been achieved the third and final step can initiated. This step involved a side chain of triazolinone being added to the ring.  Once this step has been successfully completed a stable molecule of aprepitant has been produced.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>This more streamlined route yields around 76% more aprepitant than the original process and reduces the operating cost by a significant amount. In addition, the new process also reduces the amount of solvent and reagents required by about 80% and saving an estimated 340,000L per ton of aprepitant produced.<span class="mw-ref" id="cite_ref-NYAoS2011_10-1"><a href="#cite_note-NYAoS2011-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>The improvements in the synthesis process have also decreased the long-term detriment to the natural environment associated with the original procedure, due to eliminating the use of several hazardous chemicals.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>It was approved by the Food and Drug Administration (FDA) in 2003.<span class="mw-ref" id="cite_ref-urlDrug_Approval_Package:_EMEND_(Aprepitant)_NDA_#21-549_12-0"><a href="#cite_note-urlDrug_Approval_Package:_EMEND_(Aprepitant)_NDA_#21-549-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In 2008, fosaprepitant, an intravenous form of aprepitant was approved in the United States.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Major_depression">Major depression</h3></summary>
    
<p>Plans to develop aprepitant as an antidepressant have been withdrawn.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Subsequently, other trials with NK<sub>1</sub> receptor antagonists, casopitant and orvepitant, have shown promising results.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-ReferenceA_16-0"><a href="#cite_note-ReferenceA-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>Beyond suggestions that PET receptor occupancy must not be used routinely to cap dosing for new medical indications for this class,<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> or that &gt; 99% human receptor occupancy might be required for consistent psycho-pharmacological or other therapeutic effects,<span class="mw-ref" id="cite_ref-ReferenceA_16-1"><a href="#cite_note-ReferenceA-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> critical scientific dissection and debate of the above data might be needed to enable aprepitant, and the class of NK<sub>1</sub> antagonists as a whole,  to fulfill preclinically predicted utilities beyond CINV (i.e., for other psychiatric disorders, addictions, neuropathic pain, migraine, osteoarthritis, overactive bladder, inflammatory bowel disease and other disorders with suspected inflammatory or immunological components. However, most data remain proprietary and thus reviews on the expanded clinical potential for drugs like aprepitant range from optimistic<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> to poor.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2019-1"> <span id="mw-reference-text-cite_note-AHFS2019-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html'" tppabs="https://www.drugs.com/monograph/aprepitant-fosaprepitant-dimeglumine.html" class="external text external">"Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2019</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/aprepitant.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/aprepitant.html'" tppabs="https://www.drugs.com/pregnancy/aprepitant.html" class="external text external">"Aprepitant Use During Pregnancy"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2019</span>.</cite></span></li><li id="cite_note-EU2019-3"> <span id="mw-reference-text-cite_note-EU2019-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/emend  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/emend'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/emend" class="external text external">"Emend"</a>. <i>European Medicines Agency</i>. 17 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2019</span>.</cite></span></li><li id="cite_note-WHO21st-4"> <span id="mw-reference-text-cite_note-WHO21st-4" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFBergströmHargreavesBurns2004" class="citation journal cs1">Bergström, M; Hargreaves, RJ; Burns, HD;  et al. (May 2004). "Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant". <i>Biological Psychiatry</i>. <b>55</b> (10): 1007–1012. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biopsych.2004.02.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biopsych.2004.02.007'" tppabs="https://doi.org/10.1016%2Fj.biopsych.2004.02.007" class="external text external">10.1016/j.biopsych.2004.02.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15121485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15121485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15121485" class="external text external">15121485</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFGrallade_WitHerrstedtCarides2005" class="citation journal cs1">Gralla R, de Wit R, Herrstedt J, Carides A, Ianus J, Guoguang-Ma J, Evans J, Horgan K (2005). "Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials". <i>Cancer</i>. <b>104</b> (4): 864–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcncr.21222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcncr.21222'" tppabs="https://doi.org/10.1002%2Fcncr.21222" class="external text external">10.1002/cncr.21222</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15973669  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15973669'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15973669" class="external text external">15973669</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFWalshHeiligNuzzoHenderson2012" class="citation journal cs1">Walsh, S. L.; Heilig, M.; Nuzzo, P. A.; Henderson, P.; Lofwall, M. R. (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863" class="external text external">"Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers"</a>. <i>Addiction Biology</i>. <b>18</b> (2): 332–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1369-1600.2011.00419.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1369-1600.2011.00419.x'" tppabs="https://doi.org/10.1111%2Fj.1369-1600.2011.00419.x" class="external text external">10.1111/j.1369-1600.2011.00419.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354863" class="external text external">4354863</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22260216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22260216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22260216" class="external text external">22260216</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><a href="javascript:if(confirm('https://www.fda.gov/ohrms/dockets/ac/03/briefing/3928B1_01_Merck%20Backgrounder.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/ohrms/dockets/ac/03/briefing/3928B1_01_Merck%20Backgrounder.pdf'" tppabs="https://www.fda.gov/ohrms/dockets/ac/03/briefing/3928B1_01_Merck%20Backgrounder.pdf" class="external text external">FDA Advisory Committee Background Package</a></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFHale1998" class="citation journal cs1">Hale, Jeffrey J. (1998). "Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist". <i>Journal of Medicinal Chemistry</i>. <b>41</b> (23): 4607–4614. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm980299k  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm980299k'" tppabs="https://doi.org/10.1021%2Fjm980299k" class="external text external">10.1021/jm980299k</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9804700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9804700'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9804700" class="external text external">9804700</a>.</cite></span></li><li id="cite_note-NYAoS2011-10"> <span id="mw-reference-text-cite_note-NYAoS2011-10" class="mw-reference-text"><cite id="CITEREFHargreaves2011" class="citation journal cs1">Hargreaves, Richard (2011). "Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting". <i>Annals of the New York Academy of Sciences</i>. <b>1222</b> (1): 40–48. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2011NYASA1222...40H  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2011NYASA1222...40H'" tppabs="https://ui.adsabs.harvard.edu/abs/2011NYASA1222...40H" class="external text external">2011NYASA1222...40H</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.2011.05961.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.2011.05961.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.2011.05961.x" class="external text external">10.1111/j.1749-6632.2011.05961.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21434941  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21434941'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21434941" class="external text external">21434941</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFBrands2003" class="citation journal cs1">Brands, Karel M. J. (2003). "Efficient Synthesis of NK1Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective Transformation†". <i>Journal of the American Chemical Society</i>. <b>125</b> (8): 2129–2135. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fja027458g  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fja027458g'" tppabs="https://doi.org/10.1021%2Fja027458g" class="external text external">10.1021/ja027458g</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12590540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12590540'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12590540" class="external text external">12590540</a>.</cite></span></li><li id="cite_note-urlDrug_Approval_Package:_EMEND_(Aprepitant)_NDA_#21-549-12"> <span id="mw-reference-text-cite_note-urlDrug_Approval_Package:_EMEND_(Aprepitant)_NDA_#21-549-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend.cfm'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend.cfm" class="external text external">"Drug Approval Package: EMEND (Aprepitant) NDA #21-549"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-04-19</span></span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFRupniakKramer2017" class="citation journal cs1">Rupniak, NMJ; Kramer, MS (1 December 2017). "NK1 receptor antagonists for depression: Why a validated concept was abandoned". <i>Journal of Affective Disorders</i>. <b>223</b>: 121–125. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jad.2017.07.042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jad.2017.07.042'" tppabs="https://doi.org/10.1016%2Fj.jad.2017.07.042" class="external text external">10.1016/j.jad.2017.07.042</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28753469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28753469'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28753469" class="external text external">28753469</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFRattiBellewBetticaBryson2011" class="citation journal cs1">Ratti, E; Bellew, K; Bettica, P; Bryson, H; Zamuner, S; Archer, G; Squassante, L; Bye, A; Trist, D; Krishnan, K. R.; Fernandes, S (2011). "Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder". <i>Journal of Clinical Psychopharmacology</i>. <b>31</b> (6): 727–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FJCP.0b013e31823608ca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FJCP.0b013e31823608ca'" tppabs="https://doi.org/10.1097%2FJCP.0b013e31823608ca" class="external text external">10.1097/JCP.0b013e31823608ca</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22020354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22020354'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22020354" class="external text external">22020354</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFTristRattiBye2013" class="citation journal cs1">Trist, DG; Ratti, E; Bye, A (2013). "Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists". <i>J. Recept. Signal Transduct. Res</i>. <b>33</b> (6): 333–7. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F10799893.2013.843194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F10799893.2013.843194'" tppabs="https://doi.org/10.3109%2F10799893.2013.843194" class="external text external">10.3109/10799893.2013.843194</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24106886  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24106886'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24106886" class="external text external">24106886</a>.</cite></span></li><li id="cite_note-ReferenceA-16"> <span id="mw-reference-text-cite_note-ReferenceA-16" class="mw-reference-text"><cite id="CITEREFRattiBetticaAlexanderArcher2013" class="citation journal cs1">Ratti, E; Bettica, P; Alexander, R; Archer, G; Carpenter, D; Evoniuk, G; Gomeni, R; Lawson, E; Lopez, M; Millns, H; Rabiner, E. A.; Trist, D; Trower, M; Zamuner, S; Krishnan, R; Fava, M (2013). "Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies". <i>Journal of Psychopharmacology</i>. <b>27</b> (5): 424–34. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881113480990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881113480990'" tppabs="https://doi.org/10.1177%2F0269881113480990" class="external text external">10.1177/0269881113480990</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23539641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23539641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23539641" class="external text external">23539641</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFBarrettMcGuireVezinaSpitsin2013" class="citation journal cs1">Barrett, J. S.; McGuire, J; Vezina, H; Spitsin, S; Douglas, S. D. (2013). "PET measurement of receptor occupancy as a tool to guide dose selection in neuropharmacology: Are we asking the right questions?". <i>Journal of Clinical Psychopharmacology</i>. <b>33</b> (6): 725–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FJCP.0b013e3182a88654  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FJCP.0b013e3182a88654'" tppabs="https://doi.org/10.1097%2FJCP.0b013e3182a88654" class="external text external">10.1097/JCP.0b013e3182a88654</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24100788  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24100788'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24100788" class="external text external">24100788</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFHerpferLieb2005" class="citation journal cs1">Herpfer, I; Lieb, K (2005). "Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential". <i>CNS Drugs</i>. <b>19</b> (4): 275–93. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-200519040-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-200519040-00001'" tppabs="https://doi.org/10.2165%2F00023210-200519040-00001" class="external text external">10.2165/00023210-200519040-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15813642  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15813642'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15813642" class="external text external">15813642</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFGriebelHolsboer2012" class="citation journal cs1">Griebel, G; Holsboer, F (2012). <a href="javascript:if(confirm('https://zenodo.org/record/896664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/896664'" tppabs="https://zenodo.org/record/896664" class="external text external">"Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?"</a>. <i>Nature Reviews Drug Discovery</i>. <b>11</b> (6): 462–478. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrd3702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrd3702'" tppabs="https://doi.org/10.1038%2Fnrd3702" class="external text external">10.1038/nrd3702</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22596253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22596253'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22596253" class="external text external">22596253</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/aprepitant  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/aprepitant'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/aprepitant" class="external text external">"Aprepitant"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiemetics_(A04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiemetics_(A04)" style="font-size:114%;margin:0 4em">Antiemetics (A04)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">5-HT<sub>3</sub> serotonin ion<br> channel antagonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alosetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Alosetron" title="Alosetron">Alosetron</a></li>
<li>Azasetron</li>
<li>Bemesetron</li>
<li>Cilansetron</li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li>Dazopride</li>
<li><a href="Dolasetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Dolasetron" title="Dolasetron">Dolasetron</a></li>
<li><a href="Granisetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Granisetron" title="Granisetron">Granisetron</a></li>
<li>Lerisetron</li>
<li><a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li><a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">Olanzapine</a></li>
<li><a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">Ondansetron</a></li>
<li>Palonosetron (+netupitant)</li>
<li><a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">Quetiapine</a></li>
<li>Ramosetron</li>
<li>Ricasetron</li>
<li>Tropisetron</li>
<li>Zatosetron</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">5-HT serotonin G-protein<br> receptor antagonists</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li><a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">Olanzapine</a></li>
<li><a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">Risperidone</a></li>
<li><a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CB<sub>1</sub> agonists<br> (cannabinoids)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dronabinol</li>
<li><a href="Nabilone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabilone" title="Nabilone">Nabilone</a></li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a> (cannabis)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">D<sub>2</sub>/D<sub>3</sub> antagonists</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alizapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Alizapride" title="Alizapride">Alizapride</a></li>
<li>Bromopride</li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li>Clebopride</li>
<li><a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">Domperidone</a></li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Itopride</li>
<li><a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li>
<li>Metopimazine</li>
<li><a href="Prochlorperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prochlorperazine" title="Prochlorperazine">Prochlorperazine</a></li>
<li><a href="Thiethylperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiethylperazine" title="Thiethylperazine">Thiethylperazine</a></li>
<li><a href="Trimethobenzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethobenzamide" title="Trimethobenzamide">Trimethobenzamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">H<sub>1</sub> antagonists <br>(antihistamines)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cyclizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclizine" title="Cyclizine">Cyclizine</a></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Meclizine</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">mACh antagonists<br> (anticholinergics)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a> (very mild)</li>
<li><a href="Hyoscyamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyoscyamine" title="Hyoscyamine">Hyoscyamine</a></li>
<li><a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">NK<sub>1</sub> antagonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aprepitant.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprepitant" title="Aprepitant">Aprepitant</a></li>
<li>Casopitant</li>
<li>Ezlopitant</li>
<li>Fosaprepitant</li>
<li>Maropitant</li>
<li>Netupitant</li>
<li>Rolapitant</li>
<li>Vestipitant</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cerium oxalate</li>
<li><a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a></li>
<li><a href="Midazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Midazolam" title="Midazolam">Midazolam</a></li>
<li><a href="Propofol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propofol" title="Propofol">Propofol</a></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antidepressants_(N06A)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antidepressants_(N06A)" style="font-size:114%;margin:0 4em">Antidepressants (N06A)</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Specific_reuptake_inhibitors_and/or_receptor_modulators" style="font-size:114%;margin:0 4em">Specific reuptake inhibitors and/or receptor modulators</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SSRIs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a><sup>#</sup></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Indalpine<sup>‡</sup></li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paroxetine</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Zimelidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zimelidine" title="Zimelidine">Zimelidine</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SNRIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Levomilnacipran</li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NRIs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li>Viloxazine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NDRIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a><sup>‡</sup></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NaSSAs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SARIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Etoperidone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SMS</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Agomelatine</li>
<li><a href="Amisulpride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amisulpride" title="Amisulpride">Amisulpride</a></li>
<li>Esketamine<sup>†</sup></li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">Etryptamine</a><sup>‡</sup></li>
<li>Indeloxazine</li>
<li><a href="Flupentixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Flupentixol" title="Flupentixol">flupentixol</a></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a><sup>†</sup></li>
<li>Medifoxamine<sup>‡</sup></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">Metryptamine</a><sup>‡</sup></li>
<li>Oxaflozane<sup>‡</sup></li>
<li>Pivagabine<sup>‡</sup></li>
<li>Tandospirone</li>
<li>Teniloxazine</li>
<li>Tianeptine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Tricyclic_and_tetracyclic_antidepressants" style="font-size:114%;margin:0 4em">Tricyclic and tetracyclic antidepressants</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>TCAs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a><sup>‡</sup></li>
<li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a><sup>#</sup></li>
<li>Amitriptylinoxide</li>
<li>Butriptyline<sup>‡</sup></li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a><sup>#</sup></li>
<li>Demexiptiline<sup>‡</sup></li>
<li>Desipramine</li>
<li>Dibenzepin</li>
<li>Dimetacrine<sup>‡</sup></li>
<li>Dosulepin</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Imipraminoxide<sup>‡</sup></li>
<li>Iprindole<sup>‡</sup></li>
<li>Lofepramine</li>
<li>Melitracen</li>
<li>Metapramine<sup>‡</sup></li>
<li>Nitroxazepine</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li>Noxiptiline</li>
<li>Opipramol</li>
<li>Pipofezine</li>
<li>Propizepine<sup>‡</sup></li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li>
<li>Quinupramine<sup>‡</sup></li>
<li>Tianeptine</li>
<li><a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>TeCAs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">Maprotiline</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tiazesim</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_oxidase_inhibitors" style="font-size:114%;margin:0 4em">Monoamine oxidase inhibitors</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Non-selective</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Irreversible:</i> Benmoxin<sup>‡</sup></li>
<li>Iproclozide<sup>‡</sup></li>
<li><a href="Iproniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iproniazid" title="Iproniazid">Iproniazid</a><sup>‡</sup></li>
<li><a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a><sup>#</sup></li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a><sup>#</sup></li>
<li>Mebanazine<sup>‡</sup></li>
<li><a href="Nialamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nialamide" title="Nialamide">Nialamide</a><sup>‡</sup></li>
<li>Octamoxin<sup>‡</sup></li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>Pheniprazine<sup>‡</sup></li>
<li>Phenoxypropazine<sup>‡</sup></li>
<li>Pivhydrazine<sup>‡</sup></li>
<li>Safrazine<sup>‡</sup></li>
<li>Tedizolid</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li></ul>

<ul><li><i>Reversible:</i> Caroxazone<sup>‡</sup></li></ul>

<ul><li><i>Mixed:</i> Bifemelane</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>MAO<sub>A</sub></abbr>-selective</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Reversible:</i> Eprobemide</li>
<li>Metralindole</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a><sup>‡</sup></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li>Pirlindole</li>
<li>Tetrindole</li>
<li>Toloxatone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>MAO<sub>B</sub></abbr>-selective</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Irreversible:</i> <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Adjunctive_therapies" style="font-size:114%;margin:0 4em">Adjunctive therapies</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Atypical antipsychotics (<a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, brexpiprazole, lurasidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>)</li>
<li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Lithium (<a href="Lithium_carbonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Lithium_carbonate" title="Lithium carbonate">lithium carbonate</a>, lithium citrate)</li>
<li><a href="Thyroid_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyroid_hormone" title="Thyroid hormone" class="mw-redirect">Thyroid hormones</a> (<a href="Triiodothyronine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triiodothyronine" title="Triiodothyronine">triiodothyronine</a> (T<sub>3</sub>), <a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">levothyroxine</a> (T<sub>4</sub>))</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Miscellaneous" style="font-size:114%;margin:0 4em">Miscellaneous</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="S-Adenosyl_methionine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ademetionine" title="Ademetionine" class="mw-redirect">Ademetionine (<abbr>SAMe</abbr>)</a></li>
<li><i>Hypericum perforatum</i> (St. John's Wort)</li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxitriptan" title="Oxitriptan" class="mw-redirect">Oxitriptan (<abbr>5-HTP</abbr>)</a></li>
<li><a href="Rubidium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Rubidium_chloride" title="Rubidium chloride">Rubidium chloride (RbCl)</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Anxiolytics_(N05B)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Anxiolytics_(N05B)" style="font-size:114%;margin:0 4em">Anxiolytics (N05B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>5-HT<sub>1A</sub>R</abbr> agonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Gepirone<sup>†</sup></li>
<li>Tandospirone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GABA<sub>A</sub>R</abbr> <abbr>PAMs</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Benzodiazepines:</i> <a href="Adinazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Adinazolam" title="Adinazolam">Adinazolam</a></li>
<li><a href="Alprazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Alprazolam" title="Alprazolam">Alprazolam</a></li>
<li><a href="Bromazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromazepam" title="Bromazepam">Bromazepam</a></li>
<li><a href="Camazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Camazepam" title="Camazepam">Camazepam</a></li>
<li><a href="Chlordiazepoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlordiazepoxide" title="Chlordiazepoxide">Chlordiazepoxide</a></li>
<li><a href="Clobazam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Clotiazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotiazepam" title="Clotiazepam">Clotiazepam</a></li>
<li><a href="Cloxazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Cloxazolam" title="Cloxazolam">Cloxazolam</a></li>
<li><a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Ethyl_loflazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_loflazepate" title="Ethyl loflazepate">Ethyl loflazepate</a></li>
<li>Etizolam</li>
<li><a href="Fludiazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludiazepam" title="Fludiazepam">Fludiazepam</a></li>
<li><a href="Halazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Halazepam" title="Halazepam">Halazepam</a></li>
<li><a href="Ketazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketazolam" title="Ketazolam">Ketazolam</a></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li>Medazepam</li>
<li><a href="Nordazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Nordazepam" title="Nordazepam">Nordazepam</a></li>
<li><a href="Oxazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxazepam" title="Oxazepam">Oxazepam</a></li>
<li>Pinazepam</li>
<li><a href="Prazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazepam" title="Prazepam">Prazepam</a>; <i>Others:</i> Alpidem<sup>‡</sup></li>
<li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a> (e.g., <a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">phenobarbital</a>)</li>
<li><a href="Carisoprodol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carisoprodol" title="Carisoprodol">Carisoprodol</a></li>
<li>Carbamates (e.g., <a href="Meprobamate.htm" tppabs="https://ptable.com/wiki/compounds/A/Meprobamate" title="Meprobamate">meprobamate</a>)</li>
<li><a href="Chlormezanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlormezanone" title="Chlormezanone">Chlormezanone</a><sup>‡</sup></li>
<li>Ethanol (alcohol)</li>
<li>Etifoxine</li>
<li>Imepitoin; <i>Herbs:</i></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Skullcap</li>
<li>Valerian</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Gabapentinoids<br><span style="font-size:85%;">(<abbr>α<sub>2</sub>δ</abbr> <abbr>VDCC</abbr> blockers)</span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>Gabapentin enacarbil</li>
<li>Phenibut</li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antidepressants</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><abbr>SSRIs</abbr> (e.g., <a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">escitalopram</a>)</li>
<li><abbr>SNRIs</abbr> (e.g., <a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">duloxetine</a>)</li>
<li><abbr>SARIs</abbr> (e.g., <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>)</li>
<li><abbr>TCAs</abbr> (e.g., <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a><sup>#</sup>)</li>
<li><abbr>TeCAs</abbr> (e.g., <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li><abbr>MAOIs</abbr> (e.g., <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a>); <i>Others:</i> Agomelatine</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Tianeptine</li>
<li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Sympatholytics<br><span style="font-size:85%;">(Antiadrenergics)</span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alpha-1 blockers (e.g., <a href="Prazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazosin" title="Prazosin">prazosin</a>)</li>
<li>Alpha-2 agonists (e.g., <a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">clonidine</a>, <a href="Dexmedetomidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexmedetomidine" title="Dexmedetomidine">dexmedetomidine</a>, <a href="Guanfacine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanfacine" title="Guanfacine">guanfacine</a>)</li>
<li>Beta blockers (e.g., <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benzoctamine</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><a href="Cycloserine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cycloserine" title="Cycloserine">Cycloserine</a></li>
<li>Fabomotizole</li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Kanna</li>
<li>Lavender</li>
<li>Lorpiprazole</li>
<li>Mebicar</li>
<li>Mepiprazole</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li>Opipramol</li>
<li>Oxaflozane<sup>‡</sup></li>
<li>Phenaglycodol</li>
<li>Phenibut</li>
<li>Picamilon</li>
<li>Selank</li>
<li><a href="Tiagabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiagabine" title="Tiagabine">Tiagabine</a></li>
<li>Tofisopam</li>
<li>Validolum</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Neurokinin_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Neurokinin_receptor_modulators" style="font-size:114%;margin:0 4em">Neurokinin receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">NK<sub>1</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Substance P</li></ul>

<ul><li><i>Antagonists:</i> <a href="Aprepitant.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprepitant" title="Aprepitant">Aprepitant</a></li>
<li>Befetupitant</li>
<li>Burapitant</li>
<li>Casopitant</li>
<li><span class="new">CI-1021</span></li>
<li><span class="new">CP-96345</span></li>
<li><span class="new">CP-99994</span></li>
<li><span class="new">CP-122721</span></li>
<li><span class="new">Dapitant</span></li>
<li>Ezlopitant</li>
<li><span class="new">Figopitant</span></li>
<li><span class="new">FK-888</span></li>
<li>Fosaprepitant</li>
<li>Fosnetupitant</li>
<li><span class="new">GR-203040</span></li>
<li><span class="new">GW-597599</span></li>
<li><span class="new">HSP-117</span></li>
<li>L-733,060</li>
<li><span class="new">L-741,671</span></li>
<li><span class="new">L-743,310</span></li>
<li><span class="new">L-758,298</span></li>
<li>Lanepitant</li>
<li><span class="new">LY-306740</span></li>
<li>Maropitant</li>
<li>Netupitant</li>
<li><span class="new">NKP-608</span></li>
<li><span class="new">Nolpitantium besilate</span></li>
<li>Orvepitant</li>
<li>Rolapitant</li>
<li><span class="new">RP-67580</span></li>
<li><span class="new">SDZ NKT 343</span></li>
<li>Serlopitant</li>
<li><span class="new">T-2328</span></li>
<li><span class="new">Telmapitant</span></li>
<li>Tradipitant</li>
<li>Vestipitant</li>
<li>Vofopitant</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">NK<sub>2</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neurokinin A</li></ul>

<ul><li><i>Antagonists:</i> GR-159897</li>
<li>Ibodutant</li>
<li>Nepadutant</li>
<li>Saredutant</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">NK<sub>3</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Neurokinin B</li>
<li><span class="new">Senktide</span></li></ul>

<ul><li><i>Antagonists:</i> Fezolinetant (ESN-364)</li>
<li>Osanetant (SR-142,801)</li>
<li>Pavinetant (MLE-4901, AZD-2624, AZD-4901)</li>
<li><span class="new">SB-218,795</span></li>
<li><span class="new">SB-222,200</span></li>
<li>Talnetant (SB-223,412)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></li></ul>
</div></td></tr></tbody></table></div>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-29" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Aprepitant&oldid=970066853  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Aprepitant&oldid=970066853'" tppabs="https://en.wikipedia.org/wiki/?title=Aprepitant&oldid=970066853">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>